A METHOD OF EVALUATING ANTICANCER ACTIVITY OF ANTICANCER AGENT USING BY H-RAS OVER-EXPRESSING TRANSGENIC MOUSE

摘要

The present invention is a black, and more particularly, H- Ras (Ras) anti-cancer activity of the anticancer drug after administration by using a transgenic mouse with cancer susceptibility whether the anticancer agent as a method for testing the anticancer activity of the anticancer agent with a transgenic mouse or to a method of measuring the delay effect of the liver cancer.; The invention bar and evaluation of the anticancer activity of the anticancer agent and novel cancer suppression or delay the effect of significantly suppressing the generation of the tumor when administered drug showing the anti-cancer activity in mice over-expressing H- Ras causing H- Ras-derived cancer, including liver cancer a it can be usefully used in the evaluation of the visible material.